Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 19, 2021

SELL
$233.58 - $259.14 $657,761 - $729,738
-2,816 Closed
0 $0
Q1 2021

May 03, 2021

SELL
$221.91 - $258.6 $43,272 - $50,427
-195 Reduced 6.48%
2,816 $701,000
Q4 2020

Feb 09, 2021

BUY
$216.38 - $257.67 $19,690 - $23,447
91 Added 3.12%
3,011 $692,000
Q2 2020

Jul 29, 2020

BUY
$197.81 - $242.74 $577,605 - $708,800
2,920 New
2,920 $689,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Chartwell Investment Partners, LLC Portfolio

Follow Chartwell Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chartwell Investment Partners, LLC with notifications on news.